Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03498560 · ClinicalTrials.gov registry record
Examining the Association Between Pre-existing Sleep Disturbance and Postoperative Delirium
A clinical trial of Delirium, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 38
- Enrollment target
- 1
- Study location
NCT03498560: Completed study of Delirium, sponsored by Massachusetts General Hospital.
NCT03498560 is a study of Delirium that has completed, run by Massachusetts General Hospital. The registered enrollment target is 38 participants, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03498560, a study of Delirium, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are performing this research study to understand the role of sleep disturbance on the incidence/severity of delirium after surgery. The investigators will study the brain using a polysomnography device (PSG), which records the brain's electrical activity during sleep.
Primary Outcome
Duration of sleep in delirious vs non-delirious patients
Conditions Studied
Interventions
- DEVICE PSG
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2019-09-01 |
What the finished NCT03498560 record still lists
NCT03498560 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which PSG is the first listed.
NCT03498560 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03498560 about?
NCT03498560 is a clinical study titled "Examining the Association Between Pre-existing Sleep Disturbance and Postoperative Delirium". The investigators are performing this research study to understand the role of sleep disturbance on the incidence/severity of delirium after surgery. The investigators will study the brain using a polysomnography device (PSG), which records the brain's electrical activity during sleep.
What is the current status of trial NCT03498560?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2018-11-01. Estimated completion is 2019-09-01.
What conditions does trial NCT03498560 study?
This clinical trial studies the following conditions: Delirium.
What interventions are being tested in trial NCT03498560?
The interventions under investigation include: PSG (DEVICE).
Who is sponsoring clinical trial NCT03498560?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03498560 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delirium
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03498560's enrollment target sits among peer trials
38 55th of 62 higher than 8 of 62 other Delirium trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Delirium trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
RECRUITING · NA
-
VoiceLove Digital Therapy for Delirium in the ICU
RECRUITING · NA
-
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
RECRUITING · NA
-
TaVNS for Delirium
RECRUITING · NA
-
Neurosteer Bedside Monitoring System
RECRUITING · NA
-
Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI